Navigation Links
Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
Date:9/22/2008

$111 billion, and net income rose by 2%. Total revenue for all publicly traded medtech companies in the US, including medtech divisions of conglomerates, reached over US$180 billion in 2007.

The Pulse of the industry report also identifies emerging risks and challenges that could negatively impact development cycles and capital requirements for medtech companies in the near future. These include growing pricing pressures from governments and third-party insurers, increased regulatory oversight, product safety concerns and new regulations, which are limiting traditional methods for cooperating with physicians on product development and refinement.

"With approximately two-thirds of all medtech revenue coming from products two years old or less, company innovation has long been an essential requirement for success in the industry," remarked John Babitt, Senior Manager, Transaction Advisory Services. "As medtech companies tackle a growing litany of challenges, they will need to apply an innovative approach in rethinking traditional elements of the medtech business model and in demonstrating the true value of their products in an environment of increased scrutiny and regulation."

About Ernst & Young's Global Biotechnology Center

Today's rapidly changing biotechnology and medical technology industries are delivering new levels of health, prosperity and sustainability. But they are also facing unprecedented challenges. Ernst & Young's Global Biotechnology Center brings together a worldwide team of professionals to help you achieve your potential -- a team with deep technical experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends, identify the implications and develop points of view on relevant industry issues. Ultimately it enables us to help you meet your goals and compete more effectively. It's how Ernst & Young makes a difference.

About Ernst & Young

Ernst & Young
'/>"/>

SOURCE Ernst & Young LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
2. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
3. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
4. Abbott to Present at UBS Best of Americas Investment Conference
5. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
6. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
8. The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
9. Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments?
10. Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
11. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 GeneWEAVE, Inc ... (MDROs), announced that initial feasibility data supporting the ... and susceptibility testing from positive blood cultures will ... 31, 2015 in New Orleans, LA. The Company’s ... diagnostics that can quickly detect bacteria and assess ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Market ... (Chem-Report ) signed a partnership agreement for quality ... authorised to distribute and sell research reports worked ... at Partners Department, commented upon the agreement: “Chem-Report ... on key petroleum and chemical markets on global ...
(Date:5/29/2015)... 2015  Caris Life Sciences® today announced the ... researchers utilized Caris Molecular Intelligence®, the company,s panomic, ... targets in patients with colorectal and pancreatic cancer ... death protein 1 (PD-1) and its ligand, PD-L1. ... 2015 American Society of Clinical Oncology Annual Meeting ...
(Date:5/29/2015)... Md. and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that Roger Jeffs ... will provide an overview and update on the company,s business ... New York City . The presentation and ... June 4, 2015, at 11:00 AM Eastern Time, and can ...
Breaking Biology Technology:Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 2Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4
... Raymond and Ruth Perelman School of Medicine at ... of a first-of-its-kind interdisciplinary center focused on discovering ... bring together, without institutional walls, all necessary approaches ... research support facilities, translating findings into therapies, fostering ...
...   Elsevier, the leading provider of scientific, ... to outstanding members of the wilderness medicine community at this ... Conference & Annual Meeting , taking place in Snowmass, CO, ... The aim of the Wilderness Medicine Society is to ...
... 2011 Selexis SA , a global life science ... scale-up to manufacturing of therapeutic proteins announced today that CSL ... Selexis for the preclinical development of a therapeutic antibody ... in 2012. This commercial license agreement provides CSL with the ...
Cached Biology Technology:Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy 2Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members 2Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members 3CSL Limited Signs Commercial License Agreement with Selexis SA 2
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... The National Science Foundation (NSF) is funding a new ... high-achieving science and math undergraduates for teaching careers. ... within the College of Arts and Sciences at Case ... majors to become high school math and science teachers. ...
... Assistant Professor of Biomedical Engineering and Orthopedic Surgery has ... in Aging by The Ellison Medical Foundation. Case Western ... to submit a proposal, and Alsberg was one of ... National competition was strong, with only 25 awards being ...
... virulent avian influenza virus strain called H5N1 forms tiny tubules ... during viral infection, which otherwise would prompt an antiviral immune ... in an online report in the journal Nature . ... to form tiny tubules where double-stranded RNA is hidden from ...
Cached Biology News:NSF grant to launch undergrads from Case Western Reserve into math and science teaching 2NSF grant to launch undergrads from Case Western Reserve into math and science teaching 3Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award 2Protein 'tubules' free avian flu virus from immune recognition 2
...
... is a metabolically stable analog ... potent uterine stimulant and abortifacient ... to induce labor. It induces ... concentrations when given as an ...
... Biochem/physiol Actions: Glutathione-S-transferases (GSTs) are a group ... many xenobiotics in mammals. The enzymes ... thiol group of the glutathione to electrophilic ... mutagenic, carcinogenic, and toxic effects of the ...
... The National Instruments PCIe-1429 is the ... the NI PCIe-1429, you now can acquire ... bit depths available for Camera Link cameras ... synchronized data and image acquisition, fault analysis, ...
Biology Products: